Specifically, TIM-3, through the interaction with its ligand, galectin-9, downregulates the population and activity of T helper 1 (Th1) cells and promotes the “exhaustion” of T cells in many types of cancer [9,10]. This evidence concerns the gene HAVCR2 and cancer.